The vaccine, developed in partnership with WHO, is expected to significantly reduce malaria-related deaths among children under five. Health officials call it a historic step toward eliminating malaria in Nigeria.
Back to Homepage
Health
New Malaria Vaccine Approved for Nationwide Distribution in Nigeria
Vatican
August 4, 2025
Tags
Health
Related Posts
Health: US To Zero Out Tariffs On UK Pharma Under Trade Deal
The United States has agreed to eliminate tariffs on British pharmaceutical imports under a new deal requiring the UK to increase spending on American-made drugs by 25 percent. The agreement, announced Monday, aims to correct what US officials describe as long-standing trade imbalances and ensure fairer pricing for American treatments. In exchange for tariff relief, the UK’s NHS will pay higher prices for new US therapies, becoming the only country granted exemption from the steep tariffs introduced on October 1. The move comes amid broader US scrutiny of global drug-pricing practices and follows major investment commitments in US manufacturing by firms such as AstraZeneca and Pfizer.
NTS Urges FG To Prioritise Health Funding, Modernise Hospitals
The Nigerian Thoracic Society (NTS) has urged the Federal Government to prioritise increased health funding and modernise hospital infrastructure to address Nigeria’s rising burden of respiratory diseases. In a communiqué issued after its 32nd Annual General Meeting in Lagos, the society called for fully equipped regional centres of excellence, stronger documentation practices, and wider public education on tobacco risks and emergency response. Delegates also examined how technology and AI can enhance respiratory care, stressing that while AI offers major benefits, it cannot replace healthcare professionals.
Cervical Cancer Vaccine Push Has Saved 1.4 Million Lives — Gavi
Gavi, the Vaccine Alliance, says its three-year campaign to expand access to HPV vaccines in low-income countries has prevented an estimated 1.4 million future cervical cancer deaths. The organisation reports that 86 million girls are now protected against HPV—the leading cause of cervical cancer—which disproportionately affects poorer nations lacking screening and treatment services. HPV-related cervical cancer caused 350,000 deaths in 2022, with 90% occurring in low-income countries. Gavi added that vaccine coverage in Africa has risen from 4% in 2014 to 44% in 2024, supported by reduced vaccine prices and increased manufacturer commitments.